Daniel Zolnierz

Daniel Zolnierz is a seasoned Pharmaceutical Director with extensive leadership experience in launch strategy, marketing, and commercial operations.

His background encompasses 8 years in management consulting, focusing on commercial, marketing, and launch excellence leadership, underpinned by strong analytical skills and strategic business acumen.

Daniel is dedicated to driving decisions through insightful analysis and fostering a culture of excellence within the organizations he serves.

His expertise includes advisory leadership on multiple product launches, strategic commercial planning, and project execution across various therapeutic areas, including rare diseases.

Daniel has contributed significantly to the eminence of the US healthcare industry by analyzing profitability trends and emerging market dynamics.

He excels in conducting market assessments to guide competitive positioning strategies and go-to-market plans.

Collaborating with senior executives, Daniel plays a key role in developing implementation roadmaps and driving commercialization strategies.

His proficiency extends to commercial capability development, marketing excellence, and overall commercial operational effectiveness.

Daniel possesses cross-functional knowledge that is valuable across different sizes of pharmaceutical companies, from start-ups to large corporations.

Education-wise, Daniel Zolnierz pursued an MBA in Global Strategic Management from Babson College's Franklin W. Olin Graduate School of Business.

He also holds a Bachelor of Science in Business Administration with a focus on Finance and Management from Babson College.

Additionally, he studied Management and Political Science at the London School of Economics and Political Science.

Daniel has held various key positions in prestigious organizations, including Business Unit Director at Merck's Healthcare Business and Director, Global Marketing, Neurology & Immunology Franchise at EMD Serono, Inc.

He also served as Associate Director in Global Strategic Launch Management at EMD Serono, Inc., Manager in Healthcare and Life Sciences at Deloitte Consulting, and Private Equity Analyst at Castle Island Partners.

His professional journey includes roles as a Consultant in Finance Strategy at Deloitte Consulting, participation in GE Capital's Financial Management Program, internship at GE Corporate Treasury as part of the Financial Management Program, and a Credit Risk Management Analyst position at Morgan Stanley.